Vera Therapeutics (VERA)
(Delayed Data from NSDQ)
$26.96 USD
+0.82 (3.14%)
Updated Sep 25, 2025 04:00 PM ET
After-Market: $26.99 +0.03 (0.11%) 7:58 PM ET
4-Sell of 5 4
D Value D Growth D Momentum F VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
VERA 26.96 +0.82(3.14%)
Will VERA be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for VERA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for VERA
Wall Street Analysts Think Vera Therapeutics (VERA) Could Surge 27.26%: Read This Before Placing a Bet
VERA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for VERA
VERA forms NR7 on September 25
VERA forms Stochastic Sell Signal on September 23
VERA forms Slingshot Bullish on September 23
VERA forms Upper Bollinger Band Walk on September 19
180 Bullish Setup appears for VERA after 7.33% move